Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Cell Immunol. 2010 Oct 16;266(2):187–191. doi: 10.1016/j.cellimm.2010.10.003

Table 1.

Clinical Characteristics of HCV-infected subjects

HCV viral load
subject age genotype ALT AST PLT ALB APRI
1 53 1,782,120 3a 29 22 278 3.8 0.18
2 49 125,419 1a 21 19 215 3.7 0.20
3 46 4,608,270 1a 73 136 243 4 1.24
4 65 632,416 2a 56 54 181 4.1 0.66
5 58 783 NA 36 28 332 4.2 0.19
6 57 464,082 1a 95 115 135 2.9 1.89
7 63 1,924,230 1a 54 39 197 4 0.44
8 60 185,662 1a 45 30 262 4.1 0.25
9 53 110,741 1b 58 30 209 4.1 0.32
10 49 1,168,790 3 272 207 248 3.8 1.85
11 62 332,882 1a 94 111 134 3.6 1.84
12 52 2,003,560 1b 95 75 132 4 1.26
13 62 132,541 1 50 49 229 4.3 0.48
14 60 2,070,000 1a 30 33 322 4.1 0.23

HCV viral load, ALT U/L, AST U/L, PLT in thousands, ALB g/dL, APRI (aspartate aminotransferase/platelet ratio index)